Skip to main content
Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.910
+0.040 (2.14%)
At close: Jun 26, 2026, 4:00 PM EDT
1.850
-0.060 (-3.14%)
After-hours: Jun 26, 2026, 7:06 PM EDT

Inhibikase Therapeutics Employees

Inhibikase Therapeutics had 35 employees as of December 31, 2025. The number of employees increased by 19 or 118.75% compared to the previous year.

Employees
35
Change (1Y)
19
Growth (1Y)
118.75%
Revenue / Employee
n/a
Profits / Employee
-$1,456,037
Market Cap
325.51M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20253519118.75%
Dec 31, 202416777.78%
Dec 31, 20239228.57%
Dec 31, 202270-
Dec 31, 202174133.33%
Dec 31, 2020 Pro Pro Pro

Related Stocks

Company Name Employees
MacroGenics 293
Abeona Therapeutics 226
Rocket Pharmaceuticals 202
Verastem 102
Neumora Therapeutics 92
Lineage Cell Therapeutics 77
Immuneering 55
DiaMedica Therapeutics 35
Employee Rankings

IKT News

More News